Top COPD and Asthma Devices Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the COPD and Asthma Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading COPD and Asthma Devices industry players.

COPD and Asthma Devices Market Competitive Landscape

Global COPD and Asthma Devices Market is highly competitive and fragmented due to the presence of a few prominent players. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. Major players include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co. and Philips Healthcare among others. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Top Players in COPD and Asthma Devices Market

  • AstraZeneca Plc. (United Kingdom) 
  • GlaxoSmithKline Plc. (United Kingdom) 
  • Merck & Co., Inc. (United States) 
  • Novartis AG (Switzerland) 
  • 3M Company (United States) 
  • Baxter International Inc. (United States) 
  • ResMed Inc. (United States) 
  • Teva Pharmaceutical Industries Ltd. (Israel) 
  • Cipla Ltd. (India) 
  • Omron Healthcare, Inc. (Japan) 
  • Invacare Corporation (United States) 
  • Masimo Corporation (United States) 
  • Nihon Kohden Corporation (Japan) 
  • Getinge AB (Sweden) 
  • Smiths Medical (United Kingdom) 
  • Allied Healthcare Products, Inc. (United States) 
  • Aerogen Ltd. (Ireland) 
  • PARI Medical Holding GmbH (Germany) 

COPD and Asthma Devices Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global COPD and Asthma Devices Market size was valued at USD 48.78 billion in 2023 and is poised to grow from USD 51.17 billion in 2024 to USD 75.03 billion by 2032, growing at a CAGR of 4.9% during the forecast period (2025-2032). 

Global COPD and Asthma Devices Market is highly competitive and fragmented due to the presence of a few prominent players. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. Major players include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co. and Philips Healthcare among others. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'AstraZeneca Plc. (United Kingdom) ', 'GlaxoSmithKline Plc. (United Kingdom) ', 'Merck & Co., Inc. (United States) ', 'Novartis AG (Switzerland) ', '3M Company (United States) ', 'Baxter International Inc. (United States) ', 'ResMed Inc. (United States) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'Cipla Ltd. (India) ', 'Omron Healthcare, Inc. (Japan) ', 'Invacare Corporation (United States) ', 'Masimo Corporation (United States) ', 'Nihon Kohden Corporation (Japan) ', 'Getinge AB (Sweden) ', 'Smiths Medical (United Kingdom) ', 'Allied Healthcare Products, Inc. (United States) ', 'Aerogen Ltd. (Ireland) ', 'PARI Medical Holding GmbH (Germany) '

The prevalence of respiratory conditions including COPD, asthma, and emphysema is on the rise. Additionally, there is a growing need for short-term, effective treatment as well as a growing requirement for rescue medication during abrupt asthmatic attacks. Additionally, the government's measures to raise awareness of the signs of COPD and asthma, as well as manufacturers' increased focus on the development of innovative, portable inhalation devices, are anticipated to spur market expansion.

Clinical pharmacy has a lot of opportunities with digital inhalers. Inhalers have long been a go-to for those with chronic respiratory illnesses. They constitute an interesting therapeutic option since they can administer medication directly to the lungs and avoid systemic adverse effects. Medical professionals still have trouble treating COPD and asthma (COPD). Inhaler efficacy may be lowered by poor adherence and incorrect technique. Incorrect inhaler technique and non-adherence are associated with worsening dyspnea, deteriorating health, and exacerbations of existing conditions.

North America dominated the Global COPD and Asthma Devices Market in 2021 on account of the increased prevalence of asthma and COPD together with a developed healthcare system and growing public awareness. According to the Asthma and Allergy Foundation of America (AAFA), around 1 in 13 Americans (or about 25 million individuals) had asthma in 2021, and 11 people died from the condition every day. The market is anticipated to have considerable expansion in the next years as a result of the high death rates linked to asthma and rising investment in asthma treatment in this nation. Additionally, the presence of significant market players and the development of product technologies are promoting market expansion in the area.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Respiratory Care Devices Market
Buy Now GET FREE SAMPLE
Airway Management Devices Market
Buy Now GET FREE SAMPLE
Intelligent Asthma Monitoring Devices Market
Buy Now GET FREE SAMPLE
Therapeutic Respiratory Devices Market
Buy Now GET FREE SAMPLE
Respiratory Devices Market
Buy Now GET FREE SAMPLE
Asthma Spacers Market
Buy Now GET FREE SAMPLE
Smart Inhalers Market
Buy Now GET FREE SAMPLE
Positive Airway Pressure Devices Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global COPD and Asthma Devices Market
COPD and Asthma Devices Market

Report ID: SQMIG35B2075

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE